How Long Do Drugs Stay in Your System? Half-Life Explained

If you have ever wondered why you need to take some medications three times a day while others work with a single weekly pill, or why a toxicology screen can detect marijuana use from weeks ago while cocaine disappears from blood within hours, the answer lies in a single pharmacological concept: half-life. Understanding drug half-life — and equally important, understanding where half-life falls short as a predictor — gives you a coherent framework for thinking about how medications and other substances move through your body.

The question "how long does this stay in my system?" turns out to have at least two different answers depending on what you mean by "in your system." One answer concerns pharmacological activity — how long the drug is present in sufficient concentration to produce an effect on the body. The other concerns detectability — how long a test can find evidence that the substance was consumed. These two timelines can differ dramatically. A benzodiazepine may lose therapeutic effects within hours while remaining detectable in urine for weeks. Heroin is converted in the body so rapidly that it barely registers in testing, but its metabolites tell the story for days. Hair follicle tests can detect drug use from months before the test. Half-life is the foundation, but it is only the beginning of the full picture.

This article walks through what half-life means in plain language, how it mathematically determines clearance time, a detailed reference table of half-lives for dozens of common drugs, how drug testing detection windows differ from half-life predictions, the individual factors that cause the same drug to clear at very different rates in different people, and the clinical implications of half-life for dosing frequency and the risks of stopping medications abruptly.

What Is Drug Half-Life?

When a drug enters your bloodstream — whether absorbed from the gut after swallowing a tablet, injected directly into a vein, inhaled from a cigarette, or delivered through a patch on your skin — it reaches a peak concentration and then begins to decline. Your body is continuously working to eliminate it: the liver chemically transforms the drug into metabolites through enzymatic reactions, and the kidneys filter drug and metabolites out of the blood into urine. Some drugs are also eliminated through exhalation (alcohol is a partial example), through bile into stool, or through sweat.

The half-life (abbreviated t½) of a drug is defined as the time it takes for the concentration of that drug in the blood plasma to fall by exactly 50%. If a drug reaches a peak concentration of 100 units per milliliter, its half-life is the time required for that concentration to drop to 50 units per milliliter.

This exponential decay pattern is a property of what pharmacologists call first-order kinetics, which describes the elimination of the vast majority of drugs at therapeutic concentrations. In first-order elimination, the rate of removal is proportional to the current concentration: when there's a lot of drug, it's eliminated quickly; as concentration falls, the absolute rate of elimination falls proportionally. The result is that the percentage eliminated per unit time stays constant — always half per half-life.

A small number of drugs follow zero-order kinetics at therapeutic concentrations, meaning the body eliminates a fixed amount per unit time regardless of concentration. Alcohol is the most clinically important example: the liver's alcohol dehydrogenase enzyme becomes saturated, processing roughly one standard drink's worth of alcohol per hour regardless of how much you've consumed. This is why alcohol is listed in the half-life table with "~1 hour per drink" rather than a true half-life: it does not follow exponential decay, and "half-life" in the strict sense does not apply. Aspirin at higher therapeutic concentrations also shifts toward zero-order kinetics, which lengthens its effective clearance time significantly.

From Half-Life to Full Clearance: The Five Half-Lives Rule

Knowing the half-life, you can calculate approximately when a drug will be "gone" from the system. The standard pharmacological rule of thumb is that five half-lives are required to eliminate approximately 97% of a drug from the body. After five half-lives, what remains is only 1/32nd (about 3.1%) of the original amount — generally considered negligible for most clinical purposes.

You can apply this rule to any drug once you know its half-life. Ibuprofen has a half-life of approximately 2 hours, so five half-lives is about 10 hours — ibuprofen is largely cleared from the bloodstream within roughly half a day of a single use. Methadone, by contrast, has a half-life of 24 to 36 hours; five half-lives could mean 5 to 7.5 days before it is substantially eliminated. Fluoxetine (Prozac) is an extreme case: the parent drug has a half-life of 1 to 6 days, but its active metabolite norfluoxetine has a half-life of 4 to 16 days — meaning full clearance can take over 5 weeks from the last dose. This is why fluoxetine is uniquely forgiving of missed doses compared to most antidepressants, and why it does not typically require a gradual taper when being discontinued.

The five-half-lives rule also determines how long it takes for a drug to reach steady state when taken regularly — the condition where the amount being absorbed with each new dose equals the amount being eliminated between doses, producing stable blood levels. Steady state is also reached in approximately five half-lives of regular dosing. A drug with a 6-hour half-life reaches steady state within about 30 hours of starting regular use. A drug with a 7-day half-life, like levothyroxine, requires about 5 weeks to reach steady state — which is why thyroid levels are typically checked six to eight weeks after starting or changing levothyroxine, not one or two weeks later.

Half-Lives of Common Drugs: Reference Table

The following table lists half-lives for a range of commonly encountered drugs and substances. These are general ranges from published pharmacokinetic literature; individual values depend substantially on the factors discussed in the following section. Use these as reference ranges, not precise predictions for any individual.

Fluoxetine: The Remarkable Special Case

Fluoxetine deserves a closer look because its pharmacokinetics are genuinely unusual and clinically important. The parent drug — fluoxetine itself — has a half-life ranging from about 1 to 6 days depending on the individual. But fluoxetine is converted in the liver to an active metabolite called norfluoxetine, which is also pharmacologically active and has a half-life of 4 to 16 days. The combination means that the "effective" elimination of fluoxetine's activity from the body can take anywhere from 3 to over 5 weeks after the last dose.

This is the longest effective half-life of any commonly prescribed antidepressant. It has two major practical consequences. First, missing a dose of fluoxetine rarely causes the discontinuation symptoms (dizziness, "brain zaps," irritability, flu-like feelings) that are common with shorter-acting antidepressants like venlafaxine or paroxetine, because the slow self-taper prevents the abrupt concentration drop that triggers those symptoms. Second, when starting an MAOI antidepressant after discontinuing fluoxetine, a washout period of five weeks is required because any remaining fluoxetine or norfluoxetine interacting with an MAOI could produce serotonin syndrome — a potentially life-threatening condition. Contrast this with paroxetine or sertraline, which require only a 2-week washout. The half-life directly determines the required safety interval.

Drug Testing Detection Windows: Not the Same as Half-Life

A common misconception is that drug detection windows and drug half-lives are the same thing, or directly proportional. They are related but meaningfully different, and conflating them leads to significant misunderstanding — especially around drug testing.

Half-life describes what is happening in the blood plasma. Drug testing, particularly the urine tests most commonly used in employment and clinical settings, looks for drug metabolites excreted by the kidneys — not the parent drug in plasma. These metabolites are sometimes far more persistent than the parent drug. Additionally, highly fat-soluble drugs like THC are stored in body tissues and released slowly back into circulation, dramatically extending the window during which their metabolites appear in urine. Hair follicle testing operates on an entirely different principle, detecting drug deposited in growing hair rather than current blood levels, and can identify drug use from months in the past.

The following approximate detection windows illustrate how dramatically urine testing windows can diverge from plasma half-life:

• Cocaine: Plasma half-life ~1 hour. Urine: 2–4 days (benzoylecgonine metabolite).
• Heroin: Converts to morphine in minutes. 6-Acetylmorphine (specific heroin marker) urine: 6–24 hours. Morphine urine: 2–4 days.
• Amphetamine: Plasma half-life ~10–12 hours. Urine: 2–4 days.
• THC: Plasma half-life ~20–57 hours. Urine: 3 days (single use) → 30+ days (daily chronic use).
• Benzodiazepines (short-acting): Urine: 1–3 days. Long-acting (diazepam): urine 2–4 weeks.
• Opioids (codeine, oxycodone, hydrocodone): Urine: 2–4 days typically.
• Alcohol: Urine (EtG metabolite, extended testing): up to 80 hours. Standard urine: ~7–12 hours. Breath: correlates in real time.
• Nicotine (cotinine): Urine: 2–4 days. Blood: ~7–10 days for cotinine.
• Methadone: Urine: 3–12 days. Distinctive — requires specific testing because immunoassay opioid tests may not detect it.

The discrepancy between plasma half-life and urine detection window is particularly stark for THC, which is why it receives special treatment below.

Why THC Detection Is Uniquely Prolonged

THC is highly lipophilic — it dissolves readily in fat but poorly in water. After entering the bloodstream, THC rapidly leaves the plasma and distributes into fat tissue throughout the body, where it accumulates with repeated use. Over subsequent hours, days, and weeks, this stored THC is slowly released back into the circulation, where it is metabolized by the liver into 11-nor-9-carboxy-THC (THC-COOH), the water-soluble metabolite that kidneys can excrete into urine and that drug tests target.

In an occasional user, a single use may produce urine levels above the standard cutoff (50 nanograms per milliliter) for 1 to 3 days. In a daily or near-daily user, fat-tissue accumulation means THC-COOH continues to be generated and excreted for weeks after the last use — commonly 2 to 4 weeks, and occasionally longer in heavy long-term users with high body fat percentage. No other commonly tested drug has this property to the same degree. The plasma half-life of 20 to 57 hours understates the practical detection window enormously for chronic users.

Factors That Affect Drug Half-Life in Individuals

The half-life values in the table above are population averages from controlled pharmacokinetic studies. In real individuals, the actual half-life of the same drug can vary by a factor of two, five, or even more depending on physiology, genetics, and concurrent medications. Understanding these factors helps explain why two people taking the same drug can have very different experiences and why some patients need monitoring of drug levels.

Why Half-Life Determines Dosing Frequency

One of the most practical applications of half-life understanding is explaining why different drugs require such different dosing schedules. The goal of most maintenance medications is to keep drug concentrations within the therapeutic window — high enough to produce the desired effect, low enough to avoid toxicity — throughout the day. Half-life directly determines how much concentrations will fluctuate between doses and therefore how frequently dosing is needed to maintain adequate levels.

A drug with a half-life of 2 to 4 hours, like methylphenidate (Ritalin) or immediate-release morphine, drops to very low levels within hours of a dose. For a patient who needs sustained therapeutic effects throughout the day, multiple daily doses are required — or a sustained-release formulation is engineered to artificially extend the release of the drug over time, mimicking the pharmacokinetics of a longer-acting compound. This is why Concerta (an extended-release methylphenidate) can be taken once daily while immediate-release Ritalin typically requires two or three doses.

Conversely, drugs with very long half-lives can be taken once daily, once weekly, or even less frequently while maintaining stable therapeutic levels. Levothyroxine's seven-day half-life means that plasma levels barely fluctuate with once-daily dosing, and missing a single dose barely changes thyroid hormone levels at all — which is reassuring for patients who occasionally forget a tablet. Fluoxetine's extreme half-life profile means that once-weekly dosing formulations (Prozac Weekly) are pharmacologically viable. Bisphosphonates like alendronate for osteoporosis have biological half-lives in bone measured in years, allowing once-weekly or even once-monthly oral dosing.

The relationship between half-life and dosing is also why drug interactions that inhibit metabolism are clinically dangerous for some drugs. If a metabolic inhibitor effectively doubles a drug's half-life, it also doubles the time-averaged blood level at the same dosing frequency — which may push a patient from a therapeutic range into a toxic range without any change in the prescribed dose.

Why Stopping Long-Half-Life Drugs Suddenly Can Be Dangerous

The flip side of a long half-life is that the body has time to adapt to the chronic presence of the drug. Receptors and physiological systems downregulate or upregulate in response to sustained drug exposure, reaching a new equilibrium. When a drug with a long half-life is suddenly discontinued, this adapted physiology is exposed — but with the drug absent rather than present. The result can be a withdrawal or discontinuation syndrome whose severity depends on the specific drug, the duration of use, and the individual's physiology.

The most clinically serious examples involve drugs where abrupt discontinuation can be life-threatening:

• Benzodiazepines (diazepam, alprazolam, clonazepam, lorazepam): Long-term use leads to GABA receptor adaptation. Abrupt discontinuation can cause seizures, severe anxiety, hallucinations, and autonomic instability — a syndrome that can be fatal. The longer the half-life, the more gradual the natural "taper" when stopping, which is why diazepam (very long half-life) is sometimes substituted for shorter-acting benzodiazepines during withdrawal management. But even with longer-acting agents, abrupt discontinuation after significant physical dependence is dangerous.
• Corticosteroids (prednisone, dexamethasone): Long-term use suppresses the body's own cortisol production via pituitary-adrenal axis suppression. Abrupt discontinuation can produce acute adrenal insufficiency — a medical emergency characterized by severe fatigue, low blood pressure, and electrolyte disturbances.
• Antiepileptics: Stopping seizure medications abruptly, regardless of half-life, can precipitate breakthrough seizures including status epilepticus.
• Beta-blockers: Abrupt discontinuation can cause rebound hypertension, tachycardia, and in patients with underlying coronary artery disease, precipitate angina or heart attack.

Even when not immediately dangerous, stopping many medications abruptly causes significant discomfort. Antidepressant discontinuation syndrome — characterized by dizziness, electric shock-like "brain zaps," nausea, irritability, and flu-like symptoms — is particularly common with medications that have short half-lives: venlafaxine (Effexor), paroxetine (Paxil), and desvenlafaxine are among the most notorious. The rapid concentration drop triggers the syndrome. Fluoxetine, with its extraordinarily long half-life, is the major exception: the drug effectively tapers itself.

The clinical principle is always the same: do not stop any regular medication abruptly without consulting your prescriber, who can guide an appropriate taper schedule if needed. See our detailed guide on stopping medication suddenly for drug-specific information.

Frequently Asked Questions